Outsourcing R&D: Lilly Turns Work Over To Covance
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly's transition from FIPCO to FIPNET (fully integrated pharmaceutical network) sets the pace for pharma.
You may also be interested in...
Sanofi Makes Good On Outsourcing Promise In Deal With Covance
Sanofi-Aventis, which last year announced plans to transform its R&D model by tapping external sources, announced a multi-layered 10-year partnership with the contract research organization Covance Sept. 30.
Sanofi Makes Good On Outsourcing Promise In Deal With Covance
Sanofi-Aventis, which last year announced plans to transform its R&D model by tapping external sources, announced a multi-layered 10-year partnership with the contract research organization Covance Sept. 30.
Sanofi Makes Good On Outsourcing Promise In Deal With Covance
Sanofi agrees to outsource a significant portion of R&D to Covance in a 10-year deal involving payments of $1.2 billion to $2.2 billion.